Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Oral cyclosporin doesn't stop hair loss.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Oral tetracycline reduces fat breakdown in hair lipids.

Blocking DGAT1 reduces oil gland size in mice and dogs, but only mice experience hair loss.

Six African American women experienced hair loss after switching to a new HIV medication.

Finasteride interacts with terazosin, but not doxazosin; caution needed.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

IL-23 inhibitors may help treat other skin conditions, but more research is needed.

Baricitinib may help treat frontal fibrosing alopecia and facial papules.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

JAK inhibitors may help improve symptoms in adults with APECED.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

New molecules can prevent cell death in hair follicles.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.